Average Co-Inventor Count = 6.72
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbvie Deutschland Gmbh and Co Kg (11 from 167 patents)
2. Abbvie Inc. (2 from 823 patents)
3. Abbott Gmbh & Co Kg (140 patents)
11 patents:
1. 10100048 - Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
2. 9862704 - Oxindole derivatives carrying an amine-substituted piperidyl-acetidinyl substituent and use thereof for treating vasopressine-related diseases
3. 9840495 - Oxindole derivatives carrying a piperidyl-substituted azetidinyl substituent and use thereof for treating vasopressine-related diseases
4. 9688678 - Oxindole compounds carrying a nitrogen-bound spiro substituent and use thereof for treating vasopressin-related diseases
5. 9657002 - Oxindole derivatives carrying an oxetane substituent and use thereof for treating vassopressin-related diseases
6. 9617226 - Fused heterocyclic or carbocyclic compounds carrying a substituted cycloaliphatic radical and use thereof for treating vasopressin-related diseases
7. 9540370 - Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
8. 9527856 - Oxindole compounds carrying a CO-bound spiro substituent and use thereof for treating vasopressin-related diseases
9. 9273036 - Oxindole derivatives carrying an oxetane substituent and use thereof for treating vasopressine-related diseases
10. 9266855 - Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
11. 9090592 - Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors